Skip NavigationSkip to Content

Glycosylated PROLI/NO Derivatives as Nitric Oxide Prodrugs

  1. Author:
    Nandurdikar, R. S.
    Maciag, A. E.
    Hong, S. Y.
    Chakrapani, H.
    Citro, M. L.
    Keefer, L. K.
    Saavedra, J. E.
  2. Author Address

    [Nandurdikar, Rahul S.; Hong, Sam Y.; Keefer, Larry K.] NCI, Chem Sect, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA. [Maciag, Anna E.; Citro, Michael L.; Saavedra, Joseph E.] NCI, Basic Sci Program, SAIC Frederick, Frederick, MD 21702 USA. [Chakrapani, Harinath] Indian Inst Sci Educ & Res, Dept Chem, Pune 411008, Maharashtra, India.;Nandurdikar, RS, NCI, Chem Sect, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA.;nandurdikarr@mail.nih.gov saavedjo@mail.nih.gov
    1. Year: 2010
    2. Date: Jan
  1. Journal: Organic Letters
    1. 12
    2. 1
    3. Pages: 56-59
  2. Type of Article: Article
  3. ISSN: 1523-7060
  1. Abstract:

    GlcNAc-PROLI/NO prodrugs that are activated by N-acetylglucosaminidase to release nitric oxide (NO) are described. A classical acid-amine coupling is used to bifunctionalize these PROLI/NO prodrugs, which on activation generate up to 4 mol of NO, a peptide residue, and an N-acetylglucosamine residue. Many of the prodrugs synthesized are efficient sources of intracellular NO.

    See More

External Sources

  1. DOI: 10.1021/ol902481s
  2. WOS: 000272937200015

Library Notes

  1. Fiscal Year: FY2009-2010
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel